Form 4: ProKidney Corp. Executive Darin J. Weber Reports Stock Sales
SEC Form 4 Filing
Darin J. Weber, SVP of Regulatory Development at ProKidney Corp., reports the sale of Class A Ordinary Shares on April 1st and April 12th, 2024, under a pre-arranged trading plan.
Summary
- Darin J. Weber, SVP of Regulatory Development at ProKidney Corp., filed a Form 4 detailing changes in beneficial ownership.
- On April 1, 2024, Weber sold 300 Class A Ordinary Shares at a price of $1.69 per share.
- On April 12, 2024, Weber sold 84,103 Class A Ordinary Shares at a weighted average price of $1.73, with prices ranging from $1.69 to $1.77.
- These sales were executed automatically under a Rule 10b5-1 trading plan adopted on November 20, 2023.
- Following these transactions, Weber directly owns 189,670 Class A Ordinary Shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports stock sales under a pre-existing trading plan, which doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Executive stock sales are a common occurrence and are often related to personal financial planning rather than company performance. The use of a 10b5-1 plan suggests the sales were pre-planned.
Key Dates
| Date | Description |
|---|---|
| 2023-11-20 | Date of adoption of Rule 10b5-1 trading plan |
| 2024-04-01 | Date of first reported transaction: Sale of 300 shares |
| 2024-04-12 | Date of second reported transaction: Sale of 84,103 shares |
| 2024-04-16 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.